SPOTLIGHT: Study: Diabetics should take statins

For the second time this week, statins are being trumpeted for a new population. This time, it's diabetics who should be taking the cholesterol-lowering drugs; researchers found that deaths among diabetics fell by 9 percent with each statin-spawned step reduction in cholesterol. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.